Image Credit: Mainstay Medical
Mainstay is a European medical device company headquartered in Dublin, Ireland. Mainstay has developed the ReActiv8® implantable neurostimulator intended for helping people with disabling Chronic Low Back Pain.
The ReActiv8® implantable neurostimulator is designed to electrically stimulate nerves to key stabilizing muscles of the lumbar spine thereby activating these muscles. The concept is that restoration of muscle activation is an important step in the treatment of chronic low back pain.
The ReActiv8® includes two leads which are placed bilaterally near the medial branch of the dorsal ramus nerve at the L3 vertebra, and are connected to the IPG. CE approval for the device was granted in May of 2016.
According to Mainstay, the therapy is similar to exercise programs used to restore muscle control in that ReActiv8 sessions are delivered twice a day for about 30 minutes under the patient’s via a handheld wireless remote control.
Mainstay expects that over time, the stimulated activation will help the patient’s brain and body learn how to better control the muscles in between sessions, and thus recover from chronic low back pain.
Mainstay’s Medical website: http://www.mainstay-medical.com